Citation 104814

IKUINA,Y: BANDO,C: YOSHIDA,M: YANO,H: SAITOH,Y:. (1997). MS-681A, B, C AND D, NEW INHIBITORS OF MYOSIN LIGHT CHAIN KINASE FROM MYROTHECIUM SP. II. PHYSICO-CHEMICAL PROPERTIES AND STRUCTURE ELUCIDATION.. 50(12)

Citation Details

Title	MS-681A, B, C AND D, NEW INHIBITORS OF MYOSIN LIGHT CHAIN KINASE FROM MYROTHECIUM SP. II. PHYSICO-CHEMICAL PROPERTIES AND STRUCTURE ELUCIDATION.
Authors	IKUINA,Y: BANDO,C: YOSHIDA,M: YANO,H: SAITOH,Y:
Year	1997
Volume	50
Issue	12

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORSTRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	None
2	ANTIYEAST ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
3	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	WEAK ACTIVITY
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
5	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	WEAK ACTIVITY
6	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
7	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	ACTIVE
8	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
9	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
10	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MYROTHECIUM ANTIBIOTIC MS-681-AMYROTHECIUM ANTIBIOTIC MS-681-BMYROTHECIUM ANTIBIOTIC MS-681-CMYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
12	MYOSIN LIGHT CHAIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-A	ACTIVE
13	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-A	INACTIVE
14	CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-A	INACTIVE
15	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-A	INACTIVE
16	MYOSIN LIGHT CHAIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-B	ACTIVE
17	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-B	INACTIVE
18	CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-B	INACTIVE
19	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-B	INACTIVE
20	MYOSIN LIGHT CHAIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-C	ACTIVE
21	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-C	INACTIVE
22	CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-C	INACTIVE
23	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-C	INACTIVE
24	MYOSIN LIGHT CHAIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-D	ACTIVE
25	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
26	CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE
27	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYROTHECIUM ANTIBIOTIC MS-681-D	INACTIVE

Citation 104814

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1